Dynamic microenvironment and multiple damaged tissue regeneration in a de novo and synchronized manner

Regenerative medicine has rapidly developed over the past decade and created new opportunities to repair or replace tissue or organ function lost because of congenital defects, age, diseases, or serious damage （Cheng et al., 2016a; Cheng et al., 2016b）. Regenerative medicine strategies in- clude the...

Full description

Saved in:
Bibliographic Details
Published inScience China. Life sciences Vol. 59; no. 12; pp. 1332 - 1334
Main Authors Cheng, Biao, Fu, Xiaobing
Format Journal Article
LanguageEnglish
Published Beijing Science China Press 01.12.2016
Springer Nature B.V
Subjects
Biomedical and Life Sciences
Cell Differentiation - physiology
Cell Self Renewal
Humans
Insight
Life Sciences
Regeneration - physiology
Regenerative Medicine - methods
Regenerative Medicine - trends
Stem Cell Niche - physiology
Stem Cells - cytology
Stem Cells - physiology
Tissue Engineering - methods
Tissue Engineering - trends
Tissue Scaffolds
Online AccessGet full text

Cover

More Information
Summary:Regenerative medicine has rapidly developed over the past decade and created new opportunities to repair or replace tissue or organ function lost because of congenital defects, age, diseases, or serious damage （Cheng et al., 2016a; Cheng et al., 2016b）. Regenerative medicine strategies in- clude the transplantation of bioactive factors, stem cells, or biomaterials, even the induced regeneration in a de novo, depending on the application （Fu, 2014a; Huang and Fu, 2014）. However, there are several limitations to the use of regenerative medicine in the clinic with respect to using stem cells and biomaterials.
Bibliography:Regenerative medicine has rapidly developed over the past decade and created new opportunities to repair or replace tissue or organ function lost because of congenital defects, age, diseases, or serious damage （Cheng et al., 2016a; Cheng et al., 2016b）. Regenerative medicine strategies in- clude the transplantation of bioactive factors, stem cells, or biomaterials, even the induced regeneration in a de novo, depending on the application （Fu, 2014a; Huang and Fu, 2014）. However, there are several limitations to the use of regenerative medicine in the clinic with respect to using stem cells and biomaterials.
11-5841/Q
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1674-7305
1869-1889
DOI:10.1007/s11427-016-0352-1